Andreas Vogg

1.1k total citations
42 papers, 884 citations indexed

About

Andreas Vogg is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Andreas Vogg has authored 42 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Andreas Vogg's work include Radiopharmaceutical Chemistry and Applications (14 papers), Medical Imaging Techniques and Applications (6 papers) and Prostate Cancer Treatment and Research (4 papers). Andreas Vogg is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (14 papers), Medical Imaging Techniques and Applications (6 papers) and Prostate Cancer Treatment and Research (4 papers). Andreas Vogg collaborates with scholars based in Germany, Netherlands and United States. Andreas Vogg's co-authors include Felix M. Mottaghy, Agnieszka Morgenroth, Frederik A. Verburg, Florian F. Behrendt, Natascha Drude, Alexander Heinzel, Stefan Vöö, Winfried Neuhuber, Thomas Pufe and Thomas Krohn and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

Andreas Vogg

39 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Vogg Germany 16 496 412 235 191 108 42 884
Janneke D.M. Molkenboer‐Kuenen Netherlands 16 535 1.1× 267 0.6× 414 1.8× 211 1.1× 96 0.9× 33 956
Sébastien Gouard France 18 450 0.9× 178 0.4× 259 1.1× 159 0.8× 56 0.5× 37 758
Wengui Xu China 18 420 0.8× 423 1.0× 335 1.4× 225 1.2× 179 1.7× 91 1.1k
Aya Sugyo Japan 19 364 0.7× 198 0.5× 311 1.3× 272 1.4× 109 1.0× 65 848
Tore Bach‐Gansmo Norway 15 452 0.9× 356 0.9× 110 0.5× 113 0.6× 112 1.0× 45 833
Samantha Y.A. Terry United Kingdom 19 474 1.0× 186 0.5× 315 1.3× 219 1.1× 88 0.8× 49 851
Amarnath Challapalli United Kingdom 15 368 0.7× 258 0.6× 171 0.7× 170 0.9× 221 2.0× 59 816
Samuel L. Rice United States 13 246 0.5× 212 0.5× 192 0.8× 170 0.9× 63 0.6× 25 646
Gang Ren China 20 474 1.0× 251 0.6× 270 1.1× 288 1.5× 83 0.8× 62 1.0k
Mickaël Bourgeois France 22 648 1.3× 200 0.5× 319 1.4× 189 1.0× 95 0.9× 45 996

Countries citing papers authored by Andreas Vogg

Since Specialization
Citations

This map shows the geographic impact of Andreas Vogg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Vogg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Vogg more than expected).

Fields of papers citing papers by Andreas Vogg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Vogg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Vogg. The network helps show where Andreas Vogg may publish in the future.

Co-authorship network of co-authors of Andreas Vogg

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Vogg. A scholar is included among the top collaborators of Andreas Vogg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Vogg. Andreas Vogg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vogg, Andreas, Agnieszka Morgenroth, Levente K. Meszaros, et al.. (2025). Theranostic application of radiolabeled HER2-targeting single-domain antibodies (RAD202) in preclinical setting. Scientific Reports. 15(1). 38468–38468.
2.
Morgenroth, Agnieszka, et al.. (2023). Neural Stem Cells as Carriers of Nucleoside-Conjugated Nanogels: A New Approach toward Cell-Mediated Delivery. ACS Applied Materials & Interfaces. 15(18). 21792–21803. 3 indexed citations
3.
Wenzel, Barbara, Fabian Hertel, Klaus Kopka, et al.. (2023). Improved protocol for the radiosynthesis of [18F]FTC‐146: A potent and selective sigma‐1 receptor radioligand. Journal of Labelled Compounds and Radiopharmaceuticals. 66(3). 116–125. 2 indexed citations
4.
Vogg, Andreas, Jochen Maurer, Carsten Bolm, et al.. (2022). PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer. EJNMMI Research. 12(1). 60–60. 12 indexed citations
5.
Bauwens, Matthias, S. Pommé, Steffie M. B. Peters, et al.. (2020). An international multi-center investigation on the accuracy of radionuclide calibrators in nuclear medicine theragnostics. EJNMMI Physics. 7(1). 69–69. 15 indexed citations
6.
Morgenroth, Agnieszka, Mohsen Beheshti, Andreas Vogg, et al.. (2020). HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging. European Journal of Nuclear Medicine and Molecular Imaging. 48(5). 1371–1389. 79 indexed citations
7.
Morgenroth, Agnieszka, et al.. (2019). Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer. Breast Cancer Research. 21(1). 116–116. 35 indexed citations
8.
Filß, Christian, et al.. (2018). Relevant tumor sink effect in prostate cancer patients receiving 177Lu-PSMA-617 radioligand therapy. Nuklearmedizin - NuclearMedicine. 57(1). 19–25. 34 indexed citations
9.
Verburg, Frederik A., David G. Pfister, Axel Heidenreich, et al.. (2015). Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score. European Journal of Nuclear Medicine and Molecular Imaging. 43(3). 397–403. 139 indexed citations
10.
Dirkx, Ellen, Guillaume J.J.M. van Eys, Robert W. Schwenk, et al.. (2014). Protein kinase-D1 overexpression prevents lipid-induced cardiac insulin resistance. Journal of Molecular and Cellular Cardiology. 76. 208–217. 33 indexed citations
11.
Peters, Tanja, Andreas Vogg, Iris M. Oppel, & Jörn Schmaljohann. (2014). Simple and efficient synthesis of 2-[ 18 F]fluoroethyl triflate for high yield 18 fluoroethylation. Applied Radiation and Isotopes. 94. 141–146. 4 indexed citations
12.
Krohn, Thomas, Frederik A. Verburg, Thomas Pufe, et al.. (2014). [68Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice. European Journal of Nuclear Medicine and Molecular Imaging. 42(2). 210–214. 137 indexed citations
13.
Palmowski, Moritz, Andreas Vogg, Georg Mühlenbruch, et al.. (2013). Simultaneous dual-isotope SPECT/CT with 99mTc- and 111In-labelled albumin microspheres in treatment planning for SIRT. European Radiology. 23(11). 3062–3070. 9 indexed citations
14.
Morgenroth, Agnieszka, Andreas Vogg, Felix M. Mottaghy, & Jörn Schmaljohann. (2011). Targeted endoradiotherapy using nucleotides. Methods. 55(3). 203–214. 11 indexed citations
15.
Neumaier, Bernd, Felix M. Mottaghy, Andreas K. Buck, et al.. (2008). Short Communication: 18 F-Immuno-PET: Determination of Anti-CD66 Biodistribution in a Patient with High-Risk Leukemia. Cancer Biotherapy and Radiopharmaceuticals. 23(6). 819–824. 7 indexed citations
16.
Reske, S N, Gerhard Glatting, Boris D. Zlatopolskiy, et al.. (2007). 123I-ITdU-Mediated Nanoirradiation of DNA Efficiently Induces Cell Kill in HL60 Leukemia Cells and in Doxorubicin-,  -, or  -Radiation-Resistant Cell Lines. Journal of Nuclear Medicine. 48(6). 1000–1007. 20 indexed citations
17.
Vogg, Andreas, et al.. (2007). Synthesis and biodistribution of 3′-fluoro-5-[131I]iodo-2′-deoxyuridine: a comparative study of [131I]FLIdU and [18F]FLT. Nuclear Medicine and Biology. 34(3). 273–281. 1 indexed citations
18.
Buck, Andreas K., Clemens Kratochwil, Gerhard Glatting, et al.. (2007). Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT. European Journal of Nuclear Medicine and Molecular Imaging. 34(11). 1775–1782. 48 indexed citations
19.
Neumaier, Bernd, Andreas Vogg, Claudia Friesen, et al.. (2006). Synthesis and evaluation of a radiometal-labeled macrocyclic chelator-derivatised thymidine analog. Nuclear Medicine and Biology. 33(3). 359–366. 15 indexed citations
20.
Buchmann, Inga, Andreas Vogg, Gerhard Glatting, et al.. (2003). [ 18 F]5-Fluoro-2-Deoxyuridine-PET for Imaging of Malignant Tumors and for Measuring Tissue Proliferation. Cancer Biotherapy and Radiopharmaceuticals. 18(3). 327–337. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026